Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib – a Swedish model application

Author： Ghatnekar Ola   Hjalte Frida   Taylor Matthew  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.49, Iss.6, 2010-08, pp. : 851-858

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients

By Paul T.  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 2, 2010-06 ,pp. : 56-61

Springer Publishing Company

Access to resources Recommend Favorite

ABCB1 haplotypes are associated with Pgp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib

By                    

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1313-1319

Spandidos Publications

Access to resources Recommend Favorite

Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib

By                    

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 741-750

Spandidos Publications

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite

慢性髓细胞白血病对伊马替尼产生耐药性的机制 Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

By 夏君燕   朱平  

World Journal of Cancer Research, Vol. 02, Iss. 03, 2012-07 ,pp. : 15-19

汉斯出版社

Access to resources Recommend Favorite